THE USE OF CANNABIS FOR MEDICAL TREATMENT IN MALAYSIA: AN ANALYTICAL STUDY FROM THE FIQH AL-MUWAZANAT PERSPECTIVE
DOI:
https://doi.org/10.33102/inslae-proceedings.297Keywords:
Cannabis, Fiqh Al Muwazanat, Maqasid Syariah, Maslahah, MafsadahAbstract
The ongoing debate surrounding the acceptability of utilising cannabis for medical treatment remains a prominent issue. The case of Muhammad Yasin Sulaiman in 2022 became the top discussion of the whole country because he was reported of planting 17 cannabis plants to treat his bipolar disorder. Many studies show the benefits of the chemical compositions of cannabis which are Tetrahydrocannabinol (THC) and Cannabidiol (CBD) in medical treatment. More than 70 countries have recognized the use of cannabis for medical purposes. However, the law in Malaysia is still maintaining its status quo by imposing legal action on individuals who possess and distribute cannabis. This issue has caused the government to be urged to immediately allow the use of cannabis in Malaysia. This research is a qualitative study by using the data collection method and analysis of the previous written sources. Hence, this study aims to analyze the use of cannabis in medical treatment from the perspective of Fiqh al-Muwazanat. The consideration between two contradictory matters should be done to achieve the principle of maqasid sharia. The data collected was obtained from books, journal articles, official websites of the authorities, and case studies. The results of the study have shown that the use of cannabis for medical treatment in Malaysia is allowed due to the mafsadah is greater than the maslahah. This is because there is an exceptional situation where the other medicine may not be available to preserve the life of a patient, thus the necessity for the cannabis to treat the patient shall be prevailed and this is in accordance with maqasid sharia.
Downloads
References
Abdul Hakim Baharudin, Zaini Yusnita Mat Jusoh, Zanariah Dimon, Sharifah Hana Abd Rahman, & Asma Abdul Halim. (2023, Mei). Hukum penggunaan ganja menurut Islam: Satu kajian literatur. Dalam E-Prosiding Persidangan Antarabangsa Sains Sosial & Kemanusiaan Kali ke-8 (hlm. 1533–1537).
Agensi Antidadah Kebangsaan. (2022). Maklumat dadah 2022. Agensi Antidadah Kebangsaan.
Al-Burnu, M. S. (1996). Al-Wajiz fi idah qawaid al-fiqh al-kuliyyah (Edisi ke-4). Al-Resala al-Alamia Foundation.
Al-Burnu, M. S. (2003). Mausu'ah al-Qawaid al-Fiqhiyyah (Edisi ke-1, Vol. 12). Al-Resala Foundation.
Al-Khademi, N. (2001). 'Ilm al-maqasid al-shar'iyyah (Edisi ke-1). Maktabat al-'Ubaykan.
Al-Qaradhawi, Y. (1980). Al-halal wa al-haram fi al-islam (Edisi ke-13). Al-Maktab al-Islami.
Al-Qari, M. A. (2002). Mirqat al-mafatih sharh mishkat al-masabih (Edisi ke-1, Vol. 6). Dar al-Fikr.
Al-Sabuni, M. A. (2015). Rawai al-bayan tafsir ayat al-ahkam min al-quran (Edisi ke-1, Vol. 1). Dar al-Alamiyah.
Al-Shanqeeti, M. M. (1994). Ahkam al-jarahah al-tibbiyyah wa al-athar al-mutarattibah 'alaiha (Edisi ke-2). Maktabah al-Sahabah.
Al-Syafie. (2004). Musnad al-imam al-syafie (Edisi ke-1, Vol. 3). Ghiras Publishing and Distribution Company.
Al-Tayyar, A. (2011). Al-fiqh al-muyassar (Edisi ke-1, Vol. 7). Madar al-Watan Publications.
Anggi, I. (2022). Studi tentang efektivitas cannabinoid pada ganja dalam pengobatan epilepsi “review artikel”. Jurnal Pendidikan dan Konseling, 4(5), 8353–8357.
Astro Awani. (2023, September 8). Penggunaan ganja dalam perubatan, malaysia masih ketinggalan - pakar. https://www.astroawani.com/berita-malaysia/penggunaan-ganja-dalam-perubatan-malaysia-masih-ketinggalan-pakar-407543
Devinsky, O., Nabbout, R., Miller, I., Laux, L., Zolnowska, M., Wright, S., & Robert, C. (2018, November). Long-term cannabidiol treatment in patients with Dravet syndrome: An open-label extension trial. Epilepsia, 2–8.
Ekmil Krisnawati Erlen Joni, Shahrul Mizan Ismail, & Rohaida Nordin. (2023, Februari). The medicinal use of cannabis documented by Muslim scientists. International Journal of Academic Research in Business and Social Sciences, 13(2), 591–592.
Food and Drug Administration. (2023, November 28). FDA and cannabis: Research and drug approval process. https://www.fda.gov/news-events/public-health-focus/fda-and-cannabis-research-and-drug-approval-process
General Presidency of the Departments of Scholarly Research, Ifta’, Da’wah, and Guidance. (n.d.). Majalah al-Buhuth al-Islamiyyah (Vol. 23 & 32).
Huestis, M. A., Solimini, R., Pichini, S., Pacifici, R., Carlier, J., & Busardo, F. P. (2019, Mei). Cannabidiol adverse effects and toxicity. Current Neuropharmacology, 17(10), 985.
Jabatan Kemajuan Islam Malaysia. (2011). Fiqh al-muwazanat: Hubungan dan implikasinya terhadap fatwa (Edisi ke-1, Vol. 24). Darul Tenggara (M) Sdn Bhd.
Johnson, R. (2019, Mac). Defining hemp: A fact sheet. Congressional Research Service, 7, 1.
Kumar, A. (2023, Disember 7). Muhammad Lukman bin Mohamad v Public Prosecutor. Lexis Advance Malaysia Research. https://ezproxy.usim.edu.my:2071/document/onecase/?pdmfid=1522468&crid=416840f8-f1d5-459a-b41f-b08d6f337f16
Kuwait Ministry of Awqaf and Islamic Affairs. (1982). Al-Mausu'ah al-Fiqhiyyah al-Kuwaitiyah (Edisi ke-2, Vol. 11). Kuwait Ministry of Awqaf and Islamic Affairs.
Lewandowska, J., Kapala, J. M., & Puchala, L. (2021). Therapeutic potential of dronabinol: A systematic review of human trials. Farmacja Polska, 484–489.
Majmu'atu Min al-Muallifin. (2003). Fiqh al-muyassar fi daw’-il-kitab wa-sunnah (Vol. 1). King Fahd Complex for the Printing of the Holy Qur'an.
Malasevskaia, I., al-Awadhi, A. A., & Mohammed, L. (2020, Disember). Tea in the morning and khat afternoon: Health threats due to khat chewing. Cureus, 12(12), Artikel e1.
Milad, A. N. K. (2005). Al-buyu' al-muharramah wa al-manhi 'anha (Edisi ke-1). Dar al-Huda al-Nabawi.
Mohamad Haniki Nik Mohamed, Nor Ilyani Mohamed Nazar, Irna Elina Ridzwan, Nor Hidayah Mohd Taufek, & Norny Syafinaz Ab Rahman. (2022). Preventing oversight on medical cannabis legislation in Malaysia: Analysis of risks, benefits and regulation requirements. Journal of the Malaysian Parliament, 2, 11–262.
Mufti Menk. (2023, Disember 6). Weed! Is it really haram? - Mufti Menk [Video]. YouTube. https://youtu.be/tvaKtu-Do9s?si=J7bdwSzw8kVpmpKR
Omar Zin. (2022, Julai 28). Ubat mengandungi kanabis mula dibenar tahun depan. Utusan Malaysia. https://www.utusan.com.my/nasional/2022/07/produk-cbd-ada-kanabis-mula-dibenar-tahun-depan/
Pejabat Mufti Wilayah Persekutuan. (2022). Fatwa berkenaan hukum menggunakan dadah jenis kanabis bagi tujuan perubatan. Warta Kerajaan Persekutuan. https://efatwa.muftiwp.gov.my/fatwa/PUB526%20FATWA%202022%20-%20FATWA%20BERKENAAN%20HUKUM%20MENGGUNAKAN%20DADAH%20JENIS%20KANABIS%20BAGI%20TUJUAN%20PERUBATAN.
Pejabat Mufti Wilayah Persekutuan. (2023, Disember 7). Hukum menanam pokok ketum bagi tujuan perubatan & farmaseutikal. Irsyad al-Fatwa Ke-124. https://muftiwp.gov.my/ms/artikel/irsyad-fatwa/irsyad-fatwa-umum/1242-irsyad-al-fatwa-ke-124-hukum-menanam-pokok-ketum-bagi-tujuan-perubatan-farmaseutikal
Pitts, L. (2020, April). Weaving Charlotte's Web: An in-depth guide to cannabidiol [Honors thesis]. University of Mississippi.
Pratt, M., Stevens, A., Thuku, M., Butler, C., Skidmore, B., Wieland, L. S., Clemons, M., Kanji, S., & Hutton, B. (2019). Benefits and harms of medical cannabis: A scoping review of systematic reviews. Systematic Reviews, 8, 2–3.
Program Perkhidmatan Farmasi. (2023, Oktober 17). Soalan lazim: Kanabis (cannabis). Kementerian Kesihatan Malaysia. https://www.pharmacy.gov.my/v2/ms/entri/soalan-lazim-kanabis-cannabis.html
Rahmat Dapari, Mohd Hafizuddin Mahfot, Ahmad Iqmer Nashriq Mohd Nazan, Mohd Rohaizat Hassan, Nazri Che Dom, & Syed Sharizman Syed Abdul Rahim. (2022, Februari). Acceptance towards decriminalization of medical marijuana among adults in Selangor, Malaysia. PLoS ONE, 17(2), 3–15.
Shahrul Mizan Ismail, Ekmil Krisnawati Erlen Joni, & Rohaida Nordin. (2023). The legality of medical cannabis from the Islamic perspective. Journal of Malaysian and Comparative Law (JUUM), 55–61.
Silva, G. D., Del Guerra, F. B., de Oliveira Lelis, M., & Pinto, L. F. (2020). Cannabidiol in the treatment of epilepsy: A focused review of evidence and gaps. Frontiers in Neurology, 11, 1–3.
Suppiah Nachiappan, Sandra Piriya Perumalsamy, Fatimah Haji Mohd Zulkafaly, & Harikrishnan Andi. (2014). Penyalahgunaan dadah dan langkah mengatasi dari segi kognisi di Pusat Pengasih Malaysia. Jurnal Peradaban Melayu, 9, 183.
Tramer, M. R., Carroll, D., Campbell, F. A., Reynolds, D. J. M., Moore, R. A., & McQuay, H. J. (2001, Julai). Cannabinoids for control of chemotherapy induced nausea and vomiting: Quantitative systematic review. BMJ, 323, 18–19.
World Health Organization. (2020). Global HIV/AIDS statistics. https://www.who.int/news-room/fact-sheets/detail/hiv-aid
Zaheer, S., Kumar, D., Khan, M. T., Giyanwani, P. R., & Kiran, F. N. U. (2018, September). Epilepsy and cannabis: A literature review. Cureus, 10(9), Artikel e1.
Zaini Yusnita Mat Jusoh, Zanariah Dimon, Abdul Hakim Baharuddin, & Asma' Abdul Halim. (2022). Penggunaan ganja dalam rawatan penyakit mental: Tinjauan dari perspektif hukum syarak dan perundangan di Malaysia: Satu dapatan awal [Slaid PowerPoint].
Zanariah Dimon, Zaini Yusnita Mat Jusoh, Abdul Hakim Baharudin, Sharifah Hana Abd Rahman, & Asma' Abdul Halim. (2023, Mei). Kewajaran penggunaan ganja dalam perubatan: E-Prosiding Persidangan Antarabangsa Sains Sosial & Kemanusiaan kali ke-8 (hlm. 708).







